Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00367042 · ClinicalTrials.gov registry record · Phase 2

Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks

A Phase 2 study, sponsored by University of California, Davis.

Completed
Registry status
Phase 2
Development phase
98
Enrollment target

NCT00367042 is a Phase 2 study that has completed, run by University of California, Davis. The registered enrollment target is 98 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00367042, a Phase 2 study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
Phase 2
Development phase
98 participants
Enrollment target

Study Summary

Mohs Micrographic Surgery is a well established method for treatment of cutaneous malignancies. Part of this technique requires marking skin surrounding the tumor. There are two ways of marking the tissue, lightly scoring it with a scalpel or marking it with a surgical marker. This study is to determine if there is a noticeable difference in outcome between patients who have their tissue lightly scored with a scalpel or marked with a surgical marking pen.

Interventions

  • DEVICE Scalpel for tissue scoring
  • DEVICE Surgical marker for tissue marking

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2005-07
Est. Completion 2008-07
Phase Phase 2

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT00367042

The ClinicalTrials.gov registry entry for NCT00367042 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Scalpel for tissue scoring is the first listed.

NCT00367042 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00367042 about?

NCT00367042 is a clinical study titled "Study to Determine if Tissue Scored With a Scalpel Results in Any Noticeable Marks". Mohs Micrographic Surgery is a well established method for treatment of cutaneous malignancies. Part of this technique requires marking skin surrounding the tumor. There are two ways of marking the tissue, lightly scoring it with a scalpel or marking it with a surgical marker. This study is to dete...

What is the current status of trial NCT00367042?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 98 participants. The study started on 2005-07. Estimated completion is 2008-07.

What interventions are being tested in trial NCT00367042?

The interventions under investigation include: Scalpel for tissue scoring (DEVICE), Surgical marker for tissue marking (DEVICE).

Who is sponsoring clinical trial NCT00367042?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.